The Global Ophthalmic Drugs Market was valued at $29,613 million in 2016, and is projected to reach $42,663 million by 2023 Rising incidence of glaucoma, cataract, and retinal disorders across the globe Driving Market Growth Key Players: Actavis Generics (Teva Pharmaceutical Industries Ltd.), Regeneron Pharmaceuticals, Inc., and Pfizer Inc. Read More: https://bit.ly/2ENnkwC
Rising incidence of glaucoma, cataract, and retinal disorders across the globe Driving Market Growth
Key Players: Actavis Generics (Teva Pharmaceutical Industries Ltd.), Regeneron Pharmaceuticals, Inc., and Pfizer Inc.
Read More: https://bit.ly/2ENnkwC
To Top